Comparar métodos
Revisa los métodos seleccionados uno junto a otro; las filas que difieren aparecen resaltadas.
| UCLA Prostate Cancer Index× | EORTC QLQ-BR23: Calidad de Vida en Cáncer de Mama× | |
|---|---|---|
| Campo | Oncología | Oncología |
| Familia | Process / pipeline | Process / pipeline |
| Año de origen≠ | 1998 | 1996 |
| Autor original≠ | Litwin, M. S., et al. | Sprangers, M. A., et al. (EORTC Quality of Life Group) |
| Tipo | Self-report questionnaire | Self-report questionnaire |
| Fuente seminal≠ | Litwin, M. S., Hays, R. D., Fink, A., Ganz, P. A., Leake, B., & Brook, R. H. (1998). The UCLA Prostate Cancer Index: development, reliability, and validity of a health-related quality of life measure. Med Care, 36(7), 1002–1012. DOI ↗ | Sprangers, M. A., Groenvold, M., Arraras, J. I., Franklin, J., te Velde, A., Muller, M., et al. (1996). The European Organization for Research and Treatment of Cancer breast cancer-specific quality-of-life questionnaire module: first results from a three-country field study. J Clin Oncol, 14(10), 2756–2768. DOI ↗ |
| Alias≠ | UCLA PCI, PCI | QLQ-BR23 |
| Relacionados | 5 | 5 |
| Resumen≠ | The UCLA Prostate Cancer Index (UCLA PCI) is a 20-item, prostate-cancer-specific quality-of-life instrument focused on functional outcomes (urinary, sexual, bowel) rather than general cancer QoL. Developed by Litwin et al. in 1998, it has become the standard functional assessment tool in prostate cancer outcomes research, particularly for treatment comparison studies evaluating surgical vs. radiation outcomes. | The EORTC QLQ-BR23 is a 23-item breast-cancer-specific module designed to complement the 30-item EORTC QLQ-C30 core questionnaire, assessing functional and symptom domains unique to breast cancer. Validated by Sprangers et al. in 1996, it measures body image, sexual function, breast symptoms, and arm symptoms, making it a standard instrument in European and international breast cancer clinical trials and quality-of-life research. |
| ScholarGateConjunto de datos ↗ |
|
|